Zobrazeno 1 - 10
of 285
pro vyhledávání: '"Netarsudil"'
Autor:
Olivia W. Cummings, Jesús M. Meléndez-Montañez, Leah Naraine, Leyla Yavuz Saricay, Hani El Helwe, David Solá-Del Valle
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 35, Iss , Pp 102069- (2024)
Purpose: This case report highlights a possible association between netarsudil use and crystalline keratopathy. Observations: Presented here is the case of a 72-year-old woman with primary open-angle glaucoma (POAG) who developed corneal crystalline
Externí odkaz:
https://doaj.org/article/3ab594af31bd4f4aacedb8d01dadbb2a
Publikováno v:
Case Reports in Ophthalmology, Vol 15, Iss 1, Pp 369-373 (2024)
Introduction: We describe a case of reticular bullous corneal epithelial edema associated with the use of netarsudil ophthalmic solution (0.02%) for elevated intraocular pressure. Case Presentation: A 74-year-old man with a complex ocular medical his
Externí odkaz:
https://doaj.org/article/2f9e6419ea444e37a05896d5b0d13285
Publikováno v:
Indian Journal of Ophthalmology, Vol 72, Iss 3, Pp 427-431 (2024)
Purpose: To study and compare the efficacy and safety profile of Rho-kinase inhibitor (netarsudil 0.02%) and prostaglandin analog (bimatoprost 0.01%) both as monotherapy and in combination. Design: Prospective, randomized, monocentric, open-label cli
Externí odkaz:
https://doaj.org/article/1180a478438c4081bd521177e19d3d24
Autor:
Manoj Chandra Mathur, P Venkat Ratnam, S J Saikumar, Manuel John, Siddharth Ravishankar, M B Dinesh, Priya Chandil, Kishore Pahuja, Vidya Cherlikar, Sunny Wadhwani, Pankaj Bendale, Ajit Hazari, Rajesh Mishra, Susheel Deshmukh, Rahul Raja Achlerkar, Devang Tilak Shah, Chanda Hingorani, Kaivan Shah, Pratik Topiwala, Sheetal Jani, Viral G Rana, Nilay Kumar Majumdar, Debasis Chakrabarti, Rituparna Dey, Debabrata Halder, Sumit Choudhury, Ajeet Kumar, Sasmita Das, Ashok Kumar Nanda, Vidya Bhushan Kumar, Rama Dubey, Gulam Ali Kamdar, Alka Pandey, Sheetal Kishanpuria, Rajat Mohan Srivastava, Parul Singh, Sunil Kumar Verma, Neha Sharma, Rajeev Gupta
Publikováno v:
Indian Journal of Ophthalmology, Vol 71, Iss 6, Pp 2500-2503 (2023)
Purpose: Glaucoma is the second leading cause of blindness worldwide, affecting more than 64 million people aged 40-80. The best way to manage primary open-angle glaucoma (POAG) is by lowering the intraocular pressure (IOP). Netarsudil is a Rho kinas
Externí odkaz:
https://doaj.org/article/afd1b04d410c45629e29dc48fc7ef246
Publikováno v:
Oman Journal of Ophthalmology, Vol 16, Iss 1, Pp 94-97 (2023)
Rho-associated protein kinase inhibitor (ROCK) therapy for corneal endothelial dysfunction or damage other than glaucoma has been reported with few ocular side effects. We report reticular epithelial edema (REE) with netarsudil (0.02%) therapy in fou
Externí odkaz:
https://doaj.org/article/e95f41896a4244638356e73b90c904ac
Autor:
Tao Wang, Yunran Zhang, Meiling Chi, Chen Zhao, Linlin Cao, Chutong Tian, K. Kamei, Ying Zheng, Qikun Jiang
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 17, Iss 6, Pp 938-948 (2022)
Currently commercial fixed-concomitant three agents have multiple problems such as multiple dosing administration, poor efficacy and side effects. Once-daily fixed-combination timolol-netarsudil-latanoprost ophthalmic solution (FC-TNL) has the abilit
Externí odkaz:
https://doaj.org/article/f63a491b26a1477ba6966469b4fadd2f
Publikováno v:
Journal of Clinical Ophthalmology and Research, Vol 11, Iss 1, Pp 62-64 (2023)
Netarsudil (Rho-associated protein kinase inhibitor) is one of the newer anti-glaucoma medications used for the management of glaucoma. It has the most common side effects, such as conjunctival hyperemia, subconjunctival hemorrhage, and cornea vertic
Externí odkaz:
https://doaj.org/article/01a8064a38a5406fbf368dcc2cf4c6bc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Case Reports in Ophthalmology, Vol 13, Iss 2, Pp 330-335 (2022)
We report a case of a child with secondary open-angle glaucoma who developed 6.5 diopters (D) of corneal flattening upon the addition of Rhopressa (0.02% netarsudil dimesylate solution) eye drops to a preexisting treatment regimen of timolol and lata
Externí odkaz:
https://doaj.org/article/c849162ca69d424b96765931d8103732